These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12139456

  • 1. Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics.
    Chong HS, Garmestani K, Ma D, Milenic DE, Overstreet T, Brechbiel MW.
    J Med Chem; 2002 Aug 01; 45(16):3458-64. PubMed ID: 12139456
    [Abstract] [Full Text] [Related]

  • 2. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL, Govindan SV, Sharkey RM, Fisher DR, Goldenberg DM.
    J Nucl Med; 2003 Jan 01; 44(1):77-84. PubMed ID: 12515879
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
    Chong HS, Milenic DE, Garmestani K, Brady ED, Arora H, Pfiester C, Brechbiel MW.
    Nucl Med Biol; 2006 May 01; 33(4):459-67. PubMed ID: 16720237
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS, Garmestani K, Bryant LH, Milenic DE, Overstreet T, Birch N, Le T, Brady ED, Brechbiel MW.
    J Med Chem; 2006 Mar 23; 49(6):2055-62. PubMed ID: 16539394
    [Abstract] [Full Text] [Related]

  • 5. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.
    Kukis DL, DeNardo SJ, DeNardo GL, O'Donnell RT, Meares CF.
    J Nucl Med; 1998 Dec 23; 39(12):2105-10. PubMed ID: 9867151
    [Abstract] [Full Text] [Related]

  • 6. Chelators for radioimmunotherapy: I. NMR and ab initio calculation studies on 1,4,7,10-tetra(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO4Pr) and 1,4,7-tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO3A1Pr).
    Keire DA, Jang YH, Li L, Dasgupta S, Goddard WA, Shively JE.
    Inorg Chem; 2001 Aug 13; 40(17):4310-8. PubMed ID: 11487337
    [Abstract] [Full Text] [Related]

  • 7. Improved in vivo stability of actinium-225 macrocyclic complexes.
    Deal KA, Davis IA, Mirzadeh S, Kennel SJ, Brechbiel MW.
    J Med Chem; 1999 Jul 29; 42(15):2988-92. PubMed ID: 10425108
    [Abstract] [Full Text] [Related]

  • 8. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
    Sun X, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, Motekaitis R, Martell AE, Welch MJ, Anderson CJ.
    J Med Chem; 2002 Jan 17; 45(2):469-77. PubMed ID: 11784151
    [Abstract] [Full Text] [Related]

  • 9. Gallium Complexation, Stability, and Bioconjugation of 1,4,7-Triazacyclononane Derived Chelators with Azaheterocyclic Arms.
    Schmidtke A, Läppchen T, Weinmann C, Bier-Schorr L, Keller M, Kiefer Y, Holland JP, Bartholomä MD.
    Inorg Chem; 2017 Aug 07; 56(15):9097-9110. PubMed ID: 28742337
    [Abstract] [Full Text] [Related]

  • 10. Yttrium-90 chelation properties of tetraazatetraacetic acid macrocycles, diethylenetriaminepentaacetic acid analogues, and a novel terpyridine acyclic chelator.
    Stimmel JB, Stockstill ME, Kull FC.
    Bioconjug Chem; 1995 Aug 07; 6(2):219-25. PubMed ID: 7599265
    [Abstract] [Full Text] [Related]

  • 11. Efficient synthesis and evaluation of bimodal ligand NETA.
    Chong HS, Song HA, Birch N, Le T, Lim S, Ma X.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3436-9. PubMed ID: 18445528
    [Abstract] [Full Text] [Related]

  • 12. Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability.
    Schiller E, Bergmann R, Pietzsch J, Noll B, Sterger A, Johannsen B, Wunderlich G, Pietzsch HJ.
    Nucl Med Biol; 2008 Feb 01; 35(2):227-32. PubMed ID: 18312833
    [Abstract] [Full Text] [Related]

  • 13. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
    Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS.
    Nucl Med Biol; 2010 Jan 01; 37(1):57-65. PubMed ID: 20122669
    [Abstract] [Full Text] [Related]

  • 14. Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development.
    De Silva RA, Jain S, Lears KA, Chong HS, Kang CS, Sun X, Rogers BE.
    Nucl Med Biol; 2012 Nov 01; 39(8):1099-104. PubMed ID: 22743158
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
    Ferreira CL, Lamsa E, Woods M, Duan Y, Fernando P, Bensimon C, Kordos M, Guenther K, Jurek P, Kiefer GE.
    Bioconjug Chem; 2010 Mar 17; 21(3):531-6. PubMed ID: 20175523
    [Abstract] [Full Text] [Related]

  • 16. Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium.
    Šimeček J, Schulz M, Notni J, Plutnar J, Kubíček V, Havlíčková J, Hermann P.
    Inorg Chem; 2012 Jan 02; 51(1):577-90. PubMed ID: 22221285
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
    Camera L, Kinuya S, Garmestani K, Wu C, Brechbiel MW, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH.
    J Nucl Med; 1994 May 02; 35(5):882-9. PubMed ID: 8176477
    [Abstract] [Full Text] [Related]

  • 18. Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).
    Chappell LL, Rogers BE, Khazaeli MB, Mayo MS, Buchsbaum DJ, Brechbiel MW.
    Bioorg Med Chem; 1999 Nov 02; 7(11):2313-20. PubMed ID: 10632041
    [Abstract] [Full Text] [Related]

  • 19. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
    Ghosh SC, Pinkston KL, Robinson H, Harvey BR, Wilganowski N, Gore K, Sevick-Muraca EM, Azhdarinia A.
    Nucl Med Biol; 2015 Feb 02; 42(2):177-83. PubMed ID: 25457653
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.
    Chappell LL, Ma D, Milenic DE, Garmestani K, Venditto V, Beitzel MP, Brechbiel MW.
    Nucl Med Biol; 2003 Aug 02; 30(6):581-95. PubMed ID: 12900284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.